Pricing

Progenics Pharmaceuticals Inc (PGNX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark Robert Baker
Employees:
79
ONE WORLD TRADE CENTER, 47TH FLOOR, NEW YORK, NY, 10007
646-975-2500

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipelines are therapeutic agents, imaging agents for prostate cancer, and imaging analysis tools. The company was founded by Paul J. Maddon in 1986 and is headquartered in Tarrytown, NY.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available